Surgery News

The new European Society of Cardiology/European Association for Cardio-Thoracic Surgery valvular heart disease guideline includes updated recommendations on which patients should get transcatheter or surgical aortic valve replacement.

Fifteen percent of editorial commentary authors whose work accompanied randomized controlled trials on invasive CV interventions reported financial associations with trial sponsors, while many did not disclose all of their associations.

Janssen Pharmaceuticals announced that the FDA has granted an expanded indication to rivaroxaban, now allowing it for use in patients who had recent lower-extremity revascularization due to symptomatic peripheral artery disease.

During the COVID-19 pandemic, Medicare beneficiaries presented less frequently to hospitals for acute MI and stroke compared with 2018 and 2019, according to new research published in JAMA Cardiology.

Studies showed that low enrollment of women in CVD clinical trials may be influenced by myriad clinical, racial and community-related factors, according to a perspective published in the Journal of the American College of Cardiology.

Like other specialties in medicine, cardiology has seen an influx in interest in less invasive therapeutic options.

Hancock Jaffe Laboratories announced that the FDA has granted breakthrough device designation status to its bioprosthetic valve for the treatment of chronic venous insufficiency.

Among patients with cardiogenic shock, there was no difference between the inotropic agents milrinone and dobutamine in clinical outcomes, according to findings published in The New England Journal of Medicine.

The risk for aortic aneurysms among people living with HIV was increased fourfold compared with people without HIV, and HIV status was independently associated with aortic aneurysms, researchers reported.

Cleveland Clinic has been selected by U.S. News & World Report as the top U.S. hospital for cardiology and heart surgery, in the publication’s 2021-2022 Best Hospitals rankings.